Phase Ib Study of Oral Ridaforolimus in Combination With Standard Chemotherapy for Patients With Advanced Unresectable Soft Tissue Sarcoma

Trial Profile

Phase Ib Study of Oral Ridaforolimus in Combination With Standard Chemotherapy for Patients With Advanced Unresectable Soft Tissue Sarcoma

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 11 Jul 2012

At a glance

  • Drugs Docetaxel; Doxorubicin; Gemcitabine; Ifosfamide; Mesna; Ridaforolimus
  • Indications Soft tissue sarcoma
  • Focus Adverse reactions
  • Most Recent Events

    • 11 Jul 2012 Actual end date (Aug 2011) added as reported by ClinicalTrials.gov.
    • 23 Feb 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top